StreetInsider.com News Articles

Medtronic completes $550 million Scientia Vascular acquisition

Fri, 12 Jun 2026 11:00:15 -0400

Medtronic plc (NYSE: MDT) completed its acquisition of Scientia Vascular, a Salt Lake City-based medical device company, for $550 million with potential additional earn-out and milestone payments, according to a company statement.

The acquisition adds Scientia's portfolio of guidewires and catheters designed for neurovascular procedures to Medtronic's existing neurovascular product suite. Scientia, founded by John Lippert, employs approximately 310 people and develops access products for treating complex neurovascular conditions.

"The addition of Scientia's access technologies strengthens our ability to simplify complex neurovascular procedures and support physicians with more seamless solutions," said Linnea Burman, senior vice president and president of Medtronic's Neurovascular business.

Scientia's

Medtronic completes $550 million Scientia Vascular acquisition

Fri, 12 Jun 2026 11:00:15 -0400

Scientia's

Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care

Fri, 12 Jun 2026 11:00:00 -0400

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow

GALWAY, Ireland, June 12, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of Scientia Vascular, a privately-held medical device company in Salt Lake City. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition.

Scientia has developed best-in-class access products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia's portfolio of guidewires and

Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care

Fri, 12 Jun 2026 11:00:00 -0400

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow

Scientia has developed best-in-class access products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia's portfolio of guidewires and

Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care

Fri, 12 Jun 2026 11:00:00 -0400

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow

Scientia has developed best-in-class access products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia's portfolio of guidewires and

Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care

Fri, 12 Jun 2026 11:00:00 -0400

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow

Scientia has developed best-in-class access products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia's portfolio of guidewires and

Form 4 Medtronic plc For: Jun 08 Filed by: KIIL HARRY SKIP

Tue, 09 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260609/26623897.html

Form 4 Medtronic plc For: Jun 08 Filed by: KIIL HARRY SKIP

Tue, 09 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260609/26623897.html

Form 4 Medtronic plc For: Jun 04 Filed by: KIIL HARRY SKIP

Mon, 08 Jun 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260608/26618298.html

Form 4 Medtronic plc For: Jun 04 Filed by: KIIL HARRY SKIP

Mon, 08 Jun 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260608/26618298.html

Form 4 Medtronic plc For: Jun 04 Filed by: Marinaro Michael

Mon, 08 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260608/26618263.html

Form 4 Medtronic plc For: Jun 04 Filed by: Marinaro Michael

Mon, 08 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260608/26618263.html

Form 4 Medtronic plc For: Jun 04 Filed by: Martha Geoffrey

Mon, 08 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260608/26618269.html

Form 4 Medtronic plc For: Jun 04 Filed by: Martha Geoffrey

Mon, 08 Jun 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260608/26618269.html

Form 4 Medtronic plc For: Jun 05 Filed by: Blomquist Denise L.

Mon, 08 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260608/26618254.html

Form 4 Medtronic plc For: Jun 05 Filed by: Blomquist Denise L.

Mon, 08 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260608/26618254.html

Form 4 Medtronic plc For: Jun 04 Filed by: Walter Matthew R.

Mon, 08 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260608/26618259.html

Form 4 Medtronic plc For: Jun 04 Filed by: Walter Matthew R.

Mon, 08 Jun 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260608/26618259.html

Form 144 Medtronic plc Filed by: KIIL HARRY SKIP

Mon, 08 Jun 2026 14:35:00 -0400

si-local-file:///var/storage/secattach/20260608/26616732.html

Form 144 Medtronic plc Filed by: KIIL HARRY SKIP

Mon, 08 Jun 2026 14:35:00 -0400

si-local-file:///var/storage/secattach/20260608/26616732.html

Medtronic, Inc. (MDT) PT Lowered to $85 at UBS, Neutral Rating Maintained

Thu, 04 Jun 2026 09:51:03 -0400

UBS analyst Priya Sachdeva lowered the price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $90.00) while maintaining a Neutral rating.

The analyst commented, "MDT shares closed higher after a solid FY4Q26 print and seemingly conservative guidance. While CAS was clearly the bright spot -- and we think above investor expectations -- with 78% growth WW, continued share gains (+8 points in the US), and installed base momentum (40% q/q), other new product contributions also seem to be materializing (e.g. RDN, Hugo, Stealth AXiS). Combined, these business lines suggest improving execution and growing portfolio strength as MDT continues to focus

Medtronic, Inc. (MDT) PT Lowered to $85 at UBS, Neutral Rating Maintained

Thu, 04 Jun 2026 09:51:03 -0400

UBS analyst Priya Sachdeva lowered the price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $90.00) while maintaining a Neutral rating.

TD Cowen Reiterates Buy Rating on Medtronic, Inc. (MDT)

Thu, 04 Jun 2026 08:52:21 -0400

TD Cowen analyst Joshua Jennings reiterated a Buy rating and $119.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst commented: "MDT F4Q26 Beat; Solid F27 Revenue Target; F27 Execution in Focus; Overall, we are encouraged by Medtronic's F4Q26 report, which saw revenues ahead of TD Cowen/Street estimates, while EPS was in line with our/consensus expectations. We expect CRHF strength to continue in FY27, as well as headwinds in Structural Heart. We view the company's guidance as achievable and look for execution amid the extra F1Q selling week. Reiterate Buy. Overall, we are encouraged by Medtronic's 4Q26 report, which saw revenues

Medtronic, Inc. (MDT) PT Lowered to $86 at Truist Securities

Thu, 04 Jun 2026 08:28:02 -0400

(Updated - June 4, 2026 8:28 AM EDT)

Truist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $86.00 (from $95.00) while maintaining a Hold rating.

The analyst commented: "Good FY26 Finish Marked By Org. Rev Beat; FY27 Guide In-Line w/ Expects; MDT delivered a F4Q org. rev beat (6.6% vs. 5.9% CNS)--on soft mgns---while FY27 gdce was in-line w/ our thinking, but better than some might have expected---5.8% org. ex-sell week vs. 5.8% F26, and we think bears (heavily shorted into print) were bracing for decel. in the guide. F4Q saw strength in Cardio (CAS/EP) and

Medtronic, Inc. (MDT) PT Lowered to $86 at Truist Securities

Thu, 04 Jun 2026 08:28:02 -0400

(Updated - June 4, 2026 8:28 AM EDT)

Truist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $86.00 (from $95.00) while maintaining a Hold rating.